Related Experiment Videos
[Pancreatic and biliary tract cancers]
T Sawada1, N Yamada, K Hirakawa
1First Department of Surgery, Osaka City University Medical School, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|July 4, 2001
Summary
Several tumor markers, including carbohydrate antigen 19-9 (CA19-9) and SPan-1, aid in diagnosing pancreatic and biliary tract cancers. Combining these markers enhances detection rates and monitors treatment effectiveness and recurrence post-surgery.
Area of Science:
- Oncology
- Biochemistry
Context:
- Pancreatic and biliary tract cancers present diagnostic challenges.
- Tumor markers play a crucial role in managing these malignancies.
Purpose:
- To review the utility of various tumor markers for pancreatic and biliary tract cancers.
- To highlight the effectiveness of carbohydrate antigen 19-9 (CA19-9) and SPan-1.
Summary:
- Key tumor markers include carcinoembryonal antigen, pancreatic enzymes, carbohydrate antigens, and tumor-associated genes.
- CA19-9 and SPan-1, both type I carbohydrate antigens, demonstrate significant utility.
- Combination assays of these markers improve diagnostic positive rates.
Impact:
- Tumor markers are valuable for initial diagnosis.
- They aid in assessing therapeutic efficacy.
- They facilitate early detection of recurrence after surgical operations.